News

Scientists have identified dozens of human proteins that SARS-CoV-2, the virus that causes COVID-19, depends on to replicate ...
A drug that targets two parts of the deadly Nipah virus protects against infection in hamsters. And once an animal is ...
Fintel reports that on July 11, 2025, Raymond James initiated coverage of Vir Biotechnology (NasdaqGS:VIR) with a Outperform ...
Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...
A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses-using just a drop of blood.
New research has suggested that a virus that has typically been thought of as common and harmless may actually be associnrwd with an in creased risk of Par | Cell And Molecular Biology ...
As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds—ticks.
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
Researchers have developed the downstream section of a new streamlined production method for an emerging virus class.
Some antibodies neutralize the virus effectively, while others bind only weakly. Pinpointing exactly which parts of a virus ...